Literature DB >> 12662389

Co-infection with gonorrhoea and chlamydia: how much is there and what does it mean?

Sarah Creighton1, Melinda Tenant-Flowers, Christopher B Taylor, Rob Miller, Nicola Low.   

Abstract

A cross-sectional study of new clients with either gonorrhoea or chlamydia attending King's College Hospital in 1998. One thousand two hundred and thirty-nine women and 1141 men had gonorrhoea, chlamydia or both. Overall, 24.2% (124/512) of heterosexual men and 38.5% (136/353) of women with gonorrhoea also had chlamydia (P<0.001). Of heterosexual males 18.8% (124/660) and 13% (136/1022) of females with chlamydia also had gonorrhoea (P=0.002). Ethnicity had no effect on the proportion of co-infection after controlling for age and gender. Clients with dual infection were younger than those with either infection alone (P=0.0001). Over half of women and a quarter of men aged 15 to 19 years were dually infected so testing for both gonorrhoea and chlamydia may be appropriate in this age group in settings outside genitourinary clinics. The high proportion of cases of gonorrhoea that also have chlamydia justifies the policy of epidemiological treatment for chlamydia.

Entities:  

Mesh:

Year:  2003        PMID: 12662389     DOI: 10.1258/095646203321156872

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  24 in total

1.  Aptima Combo 2 testing detected additional cases of Neisseria gonorrhoeae infection in men and women in community settings.

Authors:  Julius Kapala; Kathy Biers; Michael Cox; Margaret Kamionka; Jeff Sumner; Ramandeep Toor; Jodi Gilchrist; Dan Jang; Marek Smieja; Max Chernesky
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

2.  Risk of coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in Nova Scotia.

Authors:  Kevin R Forward
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

3.  The prevalence of chlamydia, gonorrhea, and trichomonas in sexual partnerships: implications for partner notification and treatment.

Authors:  Ayesha Khan; J Dennis Fortenberry; Beth E Juliar; Wanzhu Tu; Donald P Orr; Byron E Batteiger
Journal:  Sex Transm Dis       Date:  2005-04       Impact factor: 2.830

Review 4.  Gonorrhoea.

Authors:  Sarah Creighton
Journal:  BMJ Clin Evid       Date:  2011-03-14

5.  Update on fusidic acid (CEM-102) tested against Neisseria gonorrhoeae and Chlamydia trachomatis.

Authors:  Ronald N Jones; Douglas J Biedenbach; Patricia M Roblin; Stephan A Kohlhoff; Margaret R Hammerschlag
Journal:  Antimicrob Agents Chemother       Date:  2010-07-26       Impact factor: 5.191

6.  Randomized controlled trial of the relative efficacy of high-dose intravenous ceftriaxone and oral cefixime combined with doxycycline for the treatment of Chlamydia trachomatis and Neisseria gonorrhoeae co-infection.

Authors:  Phuong Thi Thu Nguyen; Ha Viet Pham; Dung Hoang Van; Linh Van Pham; Hoi Thanh Nguyen; Hung Van Nguyen
Journal:  BMC Infect Dis       Date:  2022-07-09       Impact factor: 3.667

Review 7.  Gonorrhoea.

Authors:  Sarah Creighton
Journal:  BMJ Clin Evid       Date:  2014-02-21

8.  Coinfection Dynamics of Two Diseases in a Single Host Population.

Authors:  Daozhou Gao; Travis C Porco; Shigui Ruan
Journal:  J Math Anal Appl       Date:  2016-04-19       Impact factor: 1.583

Review 9.  Gonorrhoea.

Authors:  John S Moran
Journal:  BMJ Clin Evid       Date:  2007-03-01

10.  Current concepts in bacterial sexually transmitted diseases.

Authors:  Bong Suk Shim
Journal:  Korean J Urol       Date:  2011-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.